MOHAMMAD AZAB
CIK 1309653 · Chief Medical Officer · last filed 2026-01-13
MOHAMMAD AZAB is a Chief Medical Officer who has filed 42 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for LSTA, was dated Jan 13, 2026. Across all open-market trades the lifetime net is +$104.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.24M
5
42
$104.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LSTA | Director | 104,925 | $3.56 | $373.5K | $0 | 5 | 2026-01-13 |
| DURECT CORP (DRRX) Delisted | Director | 0 | $1.91 | $0 | $23.8K | 8 | 2025-09-12 |
| XENE | Director | 74,225 | $52.10 | $3.87M | $80.9K | 23 | 2023-12-20 |
| ASTX | Chief Medical Officer | — | $25.71 | — | $0 | 2 | 2012-12-10 |
| Astex Pharmaceuticals, Inc (SUPG) Delisted | Chief Medical Officer | — | — | — | $0 | 3 | 2011-03-28 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-13 | LSTA | Grant (A) | +30,456 | $0 | EDGAR |
| 2025-09-12 | DURECT CORP (DRRX) Delisted | Mixed | −6,000 | $0 | EDGAR |
| 2025-01-13 | LSTA | Grant (A) | +15,789 | $0 | EDGAR |
| 2024-09-27 | DURECT CORP (DRRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-11 | LSTA | Grant (A) | +19,480 | $0 | EDGAR |
| 2023-12-20 | XENE | Exer (M) | +4,320 | $42.6K | EDGAR |
| 2023-06-23 | DURECT CORP (DRRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | XENE | Grant (A) | — | $0 | EDGAR |
| 2023-01-11 | LSTA | Grant (A) | +20,000 | $0 | EDGAR |
| 2022-12-13 | XENE | Exer (M) | +3,086 | $8.3K | EDGAR |